Pages that link to "Q53558051"

The following pages link to Kinetics of diethylnitrosamine hepatocarcinogenesis in the infant mouse. (Q53558051):

Displaying 44 items.

• Alpha-fetoprotein-targeted reporter gene expression imaging in hepatocellular carcinoma (Q26741197) (← links)
• Mouse models of liver cancer: Progress and recommendations (Q26799788) (← links)
• Growth Arrest Specific 1 (Gas1) Gene Overexpression in Liver Reduces the In Vivo Progression of Murine Hepatocellular Carcinoma and Partially Restores Gene Expression Levels (Q27302934) (← links)
• The stress-regulated transcription factor CHOP promotes hepatic inflammatory gene expression, fibrosis, and oncogenesis (Q27319729) (← links)
• Mouse models in liver cancer research: A review of current literature (Q27490350) (← links)
• Deletion of Bid impedes cell proliferation and hepatic carcinogenesis (Q28507399) (← links)
• Dietary and genetic obesity promote liver inflammation and tumorigenesis by enhancing IL-6 and TNF expression (Q29615766) (← links)
• Dietary effects on liver tumor burden in mice treated with the hepatocellular carcinogen diethylnitrosamine (Q30301218) (← links)
• Altered {beta}-catenin accumulation in hepatocellular carcinomas of diethylnitrosamine-exposed rhesus macaques (Q33382038) (← links)
• Ultrastructural features of diethylnitrosamine-induced lesions in the mouse liver (Q34070690) (← links)
• STAT3 activation in monocytes accelerates liver cancer progression (Q34089708) (← links)
• Transcription cofactors TRIM24, TRIM28, and TRIM33 associate to form regulatory complexes that suppress murine hepatocellular carcinoma (Q34181413) (← links)
• Genetic and epigenetic changes in fibrosis-associated hepatocarcinogenesis in mice (Q34403470) (← links)
• The DEN and CCl4 -Induced Mouse Model of Fibrosis and Inflammation-Associated Hepatocellular Carcinoma (Q34427004) (← links)
• S-nitrosylation from GSNOR deficiency impairs DNA repair and promotes hepatocarcinogenesis (Q34904694) (← links)
• Hepatoprotective versus Oncogenic Functions of STAT3 in Liver Tumorigenesis (Q35167959) (← links)
• Biological Basis of Differential Susceptibility to Hepatocarcinogenesis among Mouse Strains (Q35633879) (← links)
• Correlation between Bcl-2 expression and histopathology in diethylnitrosamine-induced mouse hepatocellular tumors (Q35763969) (← links)
• Conditional transformation of mouse liver epithelial cells. An in vitro model for analysis of genetic events in hepatocarcinogenesis (Q35796453) (← links)
• Rat hepatocarcinogenesis induced by N-nitrosodiethylamine and N-nitrosomorpholine continuously administered at low doses. From basophilic areas of hepatocytes to hepatocellular tumors (Q35831162) (← links)
• Suppression by oestrogen of hepatocellular tumourigenesis induced in mice by 3'-methyl-4-dimethylaminoazobenzene (Q35977192) (← links)
• Molecular mechanisms of fibrosis-associated promotion of liver carcinogenesis (Q36620495) (← links)
• Characterization of copy number alterations in a mouse model of fibrosis-associated hepatocellular carcinoma reveals concordance with human disease (Q36706884) (← links)
• S-nitrosoglutathione reductase deficiency increases mutagenesis from alkylation in mouse liver (Q36814011) (← links)
• Regulation of accumulation and function of myeloid derived suppressor cells in different murine models of hepatocellular carcinoma (Q37248887) (← links)
• Role of Myc in hepatocellular proliferation and hepatocarcinogenesis. (Q37541295) (← links)
• Experimental mouse models for hepatocellular carcinoma research (Q37574072) (← links)
• The immunoreceptor NKG2D promotes tumour growth in a model of hepatocellular carcinoma (Q37622429) (← links)
• Hyperactive piggyBac transposons for sustained and robust liver-targeted gene therapy (Q40782473) (← links)
• Sequential cellular changes during chemical carcinogenesis (Q41597686) (← links)
• Nardilysin promotes hepatocellular carcinoma through activation of signal transducer and activator of transcription 3. (Q42238762) (← links)
• Initiating Activity of Diethylnitrosamine in a Rapid Production Model for Pancreatic Carcinomas in Syrian Hamsters (Q42462797) (← links)
• Enhancement of chemical hepatocarcinogenesis by the HIV-1 tat gene (Q42856892) (← links)
• Janus Kinase 2 (JAK2) Dissociates Hepatosteatosis from Hepatocellular Carcinoma in Mice. (Q46430962) (← links)
• Igf1 expression in mouse model of liver carcinogenesis (Q51803595) (← links)
• Lack of a relationship between immune function and chemically induced hepatocarcinogenesis in B6C3F1 mice. (Q53524506) (← links)
• Mice lacking RAP1 show early onset and higher rates of DEN-induced hepatocellular carcinomas in female mice (Q57281887) (← links)
• Fibrosis-associated hepatocarcinogenesis revisited: Establishing standard medium-term chemically-induced male and female models (Q58744094) (← links)
• NCR group 3 innate lymphoid cells orchestrate IL-23/IL-17 axis to promote hepatocellular carcinoma development (Q64075903) (← links)
• Carcinogenicity of diethylnitrosamine in newborn, infant, and adult mice (Q71431219) (← links)
• TIMP3 controls cell fate to confer hepatocellular carcinoma resistance (Q85864053) (← links)
• Cytokeratin 7/19 expression in N-diethylnitrosamine-induced mouse hepatocellular lesions: implications for histogenesis (Q87677698) (← links)
• Validation of miR-20a as a Tumor Suppressor Gene in Liver Carcinoma Using Hepatocyte-Specific Hyperactive piggyBac Transposons (Q90240699) (← links)
• Induction of liver-specific intrahepatic myeloid cells aggregation expands CD8 T cell and inhibits growth of murine hepatoma (Q90326749) (← links)